Info

TheraQuest is a development stage pain management company with a diversified portfolio of products for the treatment of acute and chronic pain. The market for drugs to treat pain is large and growing rapidly. In 2005, the market totaled $19 billion in the U.S. and $30 billion worldwide. This represents an approximately 6% compounded annual growth rate in the U.S. since 2001. The worldwide market is expected to grow to $35 billion by 2010. In 2005, analgesics were the fourth most prescribed medication in the U.S., with over 246 million prescriptions. Total U.S. sales for opioid analgesics were $8.2 billion in 2005, representing a compounded annual growth rate of 10% since 2001. Despite advances in drug therapy, we believe pain management remains a critical area of unmet medical need. Our goal is to become a leader in pain management pharmaceuticals by using our considerable drug development expertise to identify, develop and commercialize products with strong market potential. TheraQuest was founded by Najib Babul, PharmD and is headquartered in Blue Bell, PA. It combines internationally recognized scientific expertise of its research team with a world-class scientific advisory board.